Enzo Biochem, Inc.
ENZB · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $40 | $48 | $52 |
| Short-Term Investments | $0 | $0 | $0 | $5 |
| Receivables | $4 | $4 | $4 | $4 |
| Inventory | $6 | $6 | $6 | $7 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $48 | $52 | $60 | $70 |
| Property Plant & Equip (Net) | $15 | $15 | $15 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $15 | $15 | $16 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $64 | $68 | $75 | $86 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $16 | $21 | $19 |
| Total Curr. Liab. | $17 | $17 | $23 | $25 |
| LT Debt | $0 | $0 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $4 | $2 | $2 |
| Total NC Liab. | $3 | $4 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $20 | $21 | $28 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$302 | -$299 | -$298 | -$294 |
| AOCI | $2 | $2 | $2 | $2 |
| Other Equity | $0 | $343 | $343 | $0 |
| Total Equity | $43 | $47 | $48 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $64 | $68 | $75 | $86 |
| Net Debt | -$36 | -$40 | -$45 | -$52 |